FDA Grants Accelerated Approval to Sunvozertinib for Metastatic Non-Small Cell Lung Cancer with EGFR exon 20 Insertion Mutations By Ogkologos - July 25, 2025 316 0 Facebook Twitter Google+ Pinterest WhatsApp FDA also approved the Oncomine Dx Express Test as a companion diagnostic device Source RELATED ARTICLESMORE FROM AUTHOR Comprehensive Genomic Profiling with Subsequent Molecularly Guided Therapy Improves Outcomes Over Platinum-based Chemotherapy in Previously Untreated, Unfavourable CUP NCI and CRUK Take on Cancer’s Toughest Problems Tebentafusp Continues to Provide Long-Term OS Benefit in Previously Untreated Patients with Unresectable or Metastatic Uveal Melanoma MOST POPULAR EMA Recommends Granting a Marketing Authorisation for Generic Dasatinib February 10, 2022 Editor-in-Chief Opportunities for New ESMO Journals Launching in 2026 July 6, 2026 How CRISPR is Changing Cancer Research and Treatment July 27, 2020 ΚΑΡΚΙΝΟΣ ΣΤΟ ΣΥΚΩΤΙ February 7, 2019 Load more HOT NEWS Taking Time for the Everyday Things in 2024 Be a Holiday Helper! Woman Creates Non-Toxic Nail Polish Brand After Her Mom’s Breast Cancer... At 3-Year Follow-Up Nivolumab Plus Chemotherapy Continued to Demonstrate OS Improvement...
